Series B brings in $4mm for Carmell Therapeutics

15:40 EDT 11 Jul 2017 | Elsevier Business Intelligence

Regenerative medicine firm Carmell Therapeutics Corp. raised $4mm in its Series B financing from returning shareholders Pitts...

Original Article: Series B brings in $4mm for Carmell Therapeutics


More From BioPortfolio on "Series B brings in $4mm for Carmell Therapeutics"

Quick Search

Relevant Topics

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Complementary and Alternative Medicine
Alternative medicine are whole medical systems that did not fit with conventional medicine as they have completely different philosophies and ideas on the causes of disease, methods of diagnosis and approaches to treatment. Although often overlapping, co...